OPKO Health, Inc. (NASDAQ: OPK) (OPKO) reports business highlights and financial results for the three and nine months ended September 30, 2025. Highlights from ...

Three new Cochrane reviews find evidence that GLP-1 drugs result in clinically meaningful weight loss, but industry-funded ...

The U.S. adult obesity rate, calculated as having a BMI of 30 or higher, has gradually declined to 37% in 2025, dropping from a record high of 39.9% in 2022, according to a survey by the Gallup ...

Projections for 2026 indicate the largest single-year increase in employer health costs in 15 years, with an expected rise of ...

MeAgain is another app that pops up when you search for GLP-1 trackers. It’s pretty popular, but honestly, it’s also one of ...

Questions are swirling around the use of semaglutide, commonly sold under the brand name Ozempic, for weight loss. CBC’s ...

Revolutionary progress, like that of GLP-1 drugs, happens when many exceptional people work together, following a robust ...

Babies can be safely administered antibody protection against respiratory syncytial virus after birth even if their moms had ...

For years, MASH was where drug development dreams went to die.  | After Rezdiffra’s approval and Wegovy’s label expansion, ...

Ms. Szalavitz is a contributing Opinion writer. Jessica Massarone couldn’t concentrate in primary school: She was too preoccupied with her parents’ struggles with drug addiction. Sometimes, she’d find ...